Royalty Pharma PLC (RPRX) Social Stream

Featured Post From StockTwits About RPRX

BofA~Royalty had steady 2Q, with performance across the portfolio driving increased FY21 guidance/views gantenerumab $rhhby as an underappreciated call option, though '22 data is needed to clarify the opp.. Maint Buy/$55PT continues to view $RPRX as a source of diversified growth